Not Signed In -
Albuterol Inhaler |
Proventil HFA; Proventil Inhaler; Ventolin Inhaler |
Clinical Trial: Non-Nicotine Agents for Smoking Cessation
This study is currently recruiting patients.
|
Purpose
The primary objective of this study is to determine which is the better approach to smoking cessation in veterans: bupropion combined with transdermal nicotine or high dose nicotine replacement therapy (NRT) using transdermal nicotine combined with nicotine inhaler.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Tobacco Use Disorder | Drug: bupropion and transdermal patch Drug: transdermal patch and nicotine inhaler | Phase III |
MedlinePlus related topics: Smoking
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Uncontrolled
Study start: October 2003; Expected completion: September 2005
This study is a two-arm open-label, randomized controlled trial of bupropion combined with transdermal nicotine versus high dose NRT (transdermal nicotine and nicotine inhaler) with all subjects receiving a behavioral counseling program for smoking cessation.
Eligibility
Ages Eligible for Study: 18 Years - 65 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Readiness to set a quit date in the next two weeks,
- Current smoking of at least 15 cigarettes a day
Exclusion Criteria:
- Current untreated depression or receiving treatment for depression,
- History of seizures, major head injury, or other predisposition for seizures
Location and Contact Information
Colorado
Denver VA Medical Center, Denver, Colorado, 80220, United States; Recruiting
Alan Prochazka, M.D., M.Sc., Principal Investigator
More Information
Record last reviewed: April 2005
Last Updated: April 15, 2005
Record first received: April 15, 2005
ClinicalTrials.gov Identifier: NCT00108537
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-05-03
Source: ClinicalTrials.gov
Cache Date: May 4, 2005
Resources
- Albuterol Inhaler (Drug Digest)
- Proventil HFA (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
